Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 584 | 641 | 1,068 | 772 | 772 |
| Gross Profit | 584 | 641 | 1,068 | 772 | 772 |
| Operating Expenses | 6,228 | 8,347 | 11,325 | 13,186 | 7,992 |
| Operating Income | -5,644 | -7,706 | -10,257 | -12,414 | -7,220 |
| Interest Expense | 1,082 | 1,054 | 1,121 | 1,105 | 1,147 |
| Other Income | 1,508 | -1,485 | 1,636 | 822 | -65 |
| Pre-tax Income | -5,218 | -10,245 | -9,742 | -12,697 | -8,432 |
| Income Tax | -778 | N/A | N/A | -498 | N/A |
| Net Income Continuous | -4,441 | -10,245 | -9,742 | -12,200 | -8,432 |
| Net Income | $-4,441 | $-10,245 | $-9,742 | $-12,200 | $-8,432 |
| EPS Basic Total Ops | -4.00 | -19.60 | -20.00 | 14.00 | -42.00 |
| EPS Basic Continuous Ops | -3.86 | -17.77 | -19.79 | -23.80 | -39.06 |
| EPS Diluted Total Ops | -4.00 | -19.60 | -20.00 | 14.00 | -42.00 |
| EPS Diluted Continuous Ops | -3.86 | -17.77 | -19.79 | -23.80 | -39.06 |
| EBITDA(a) | $-4,811 | $-6,889 | $-9,434 | $-11,589 | $-6,398 |